{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:49:53Z","timestamp":1791956993446,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.athplu.2026.100609","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:31:03Z","timestamp":1791009063000},"page":"100609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Very low HDL cholesterol in infectious mononucleosis with hepatitis: a real-world evidence study"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9180-3604","authenticated-orcid":false,"given":"Iddo Z.","family":"Ben-Dov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Danoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athplu.2026.100609_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1825","article-title":"Infectious mononucleosis","volume":"350","author":"Lennon","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.athplu.2026.100609_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2010.07.016","article-title":"Epstein barr virus hepatitis","volume":"22","author":"Kofteridis","year":"2011","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.athplu.2026.100609_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.athplu.2026.100609_bib4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.athplu.2026.100609_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MOL.0b013e328051b4fe","article-title":"HDL cholesterol transport during inflammation","volume":"18","author":"van der Westhuyzen","year":"2007","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"10.1016\/j.athplu.2026.100609_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.atherosclerosis.2010.06.006","article-title":"Acute infection with epstein-barr virus is associated with atherogenic lipid changes","volume":"212","author":"Apostolou","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.athplu.2026.100609_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3947\/ic.2017.49.1.44","article-title":"Evaluation of lipid profile changes in pediatric patients with acute mononucleosis","volume":"49","author":"Sayyahfar","year":"2017","journal-title":"Infect Chemother"},{"issue":"9","key":"10.1016\/j.athplu.2026.100609_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008030","article-title":"Epstein-barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival","volume":"15","author":"Wang","year":"2019","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.athplu.2026.100609_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010254","article-title":"Epstein-barr virus oncoprotein-driven B cell metabolism remodeling","volume":"18","author":"Burton","year":"2022","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.athplu.2026.100609_bib10","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1097\/01.CCM.0000171183.79525.6B","article-title":"Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis","volume":"33","author":"Chien","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.athplu.2026.100609_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104981","article-title":"Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: systematic review, meta-analysis, and perspective of observational studies","volume":"100","author":"Taylor","year":"2024","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.athplu.2026.100609_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","article-title":"Hypolipidemia is associated with the severity of COVID-19","volume":"14","author":"Wei","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.athplu.2026.100609_bib13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.athplu.2026.100609_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2026.2616549","article-title":"Choosing real-world data for clinical and epidemiological research: methodological lessons from NHIRD and TriNetX-A narrative review","volume":"58","author":"Lin","year":"2026","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.athplu.2026.100609_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.71079\/ASIDE.IM.03222516","article-title":"TriNetX and real-world evidence: a critical review of its strengths, limitations, and bias considerations in clinical research","volume":"1","author":"Nassar","year":"2025","journal-title":"ASIDE Intern Med"},{"key":"10.1016\/j.athplu.2026.100609_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104166","article-title":"HDL cholesterol levels and susceptibility to COVID-19","volume":"82","author":"Chidambaram","year":"2022","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.athplu.2026.100609_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.M059089","article-title":"Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity","volume":"56","author":"Vaisar","year":"2015","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.athplu.2026.100609_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/ATVBAHA.108.178681","article-title":"HDL remodeling during the acute phase response","volume":"29","author":"Jahangiri","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.athplu.2026.100609_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11883-020-00901-4","article-title":"High-density lipoproteins and serum amyloid A (SAA)","volume":"23","author":"Webb","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.athplu.2026.100609_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100090","article-title":"The lipid biology of sepsis","volume":"62","author":"Amunugama","year":"2021","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.athplu.2026.100609_bib21","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1007\/s11033-021-06553-0","article-title":"New insights into the emerging effects of inflammatory response on HDL particles structure and function","volume":"48","author":"Su","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.athplu.2026.100609_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12944-021-01603-9","article-title":"Transient hypertriglyceridemia: a common finding during epstein-barr virus-induced infectious mononucleosis","volume":"20","author":"P\u00e1ez-Guill\u00e1n","year":"2021","journal-title":"Lipids Health Dis"},{"issue":"32","key":"10.1016\/j.athplu.2026.100609_bib23","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athplu.2026.100609_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1713387","article-title":"Dysfunctional high-density lipoprotein: an updated review","volume":"12","author":"Ouyang","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"25","key":"10.1016\/j.athplu.2026.100609_bib25","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.athplu.2026.100609_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis","volume":"302","author":"Soria-Florido","year":"2020","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089526000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089526000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:37:05Z","timestamp":1791956225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089526000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":26,"alternative-id":["S2667089526000647"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2026.100609","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Very low HDL cholesterol in infectious mononucleosis with hepatitis: a real-world evidence study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2026.100609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100609"}}